Robert E Landry - Net Worth and Insider Trading
Robert E Landry Net Worth
The estimated net worth of Robert E Landry is at least $19 Million dollars as of 2025-04-28. Robert E Landry is the EVP Finance CFO of Regeneron Pharmaceuticals Inc and owns about 31,969 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $19 Million. Details can be seen in Robert E Landry's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E Landry has not made any transactions after 2023-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert E Landry
Robert E Landry Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E Landry owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Robert E Landry’s form 4 insider trades.
Insider Ownership Summary of Robert E Landry
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2023-08-23 | SVP Fin & Dep CFO |
Robert E Landry Latest Holdings Summary
Robert E Landry currently owns a total of 1 stock. Robert E Landry owns 31,969 shares of Regeneron Pharmaceuticals Inc (REGN) as of August 23, 2023, with a value of $19 Million.
Latest Holdings of Robert E Landry
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2023-08-23 | 31,969 | 602.64 | 19,265,798 |
Holding Weightings of Robert E Landry
Robert E Landry Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E Landry has made a total of 23 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 23 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 223 shares on August 23, 2023, which brought Robert E Landry around $188,212.
Insider Trading History of Robert E Landry
- 1
Robert E Landry Trading Performance
Robert E Landry Ownership Network
Ownership Network List of Robert E Landry
Ownership Network Relation of Robert E Landry
Robert E Landry Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Robert E Landry is the SVP Fin & Dep CFO of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Robert E Landry made no insider transaction in Regeneron Pharmaceuticals Inc (REGN). Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 9,814 shares made by Marion Mccourt , a net sale of 1,200 shares made by Arthur F Ryan , and a net sale of 6,212 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 0 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 281,648 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 281,648 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Robert E Landry Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E Landry. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert E Landry's mailing address is: Tarrytown Ny 10591.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
